One of the challenges faced by the Chinese chip design industry is the lack of advanced domestic electronic design automation (EDA) tools. Market leaders Cadence and Synopsys are unable to supply the chipmaking software to Chinese entities due to U.S. export controls. Also, until recently, no EDA tools for chip design software could work on […]
On March 7, the House Committee on Energy and Commerce unanimously approved advancing a bill that would give TikTok six months to divest from its parent company ByteDance or face a potential ban. The “Protecting Americans From Foreign Adversary Controlled Applications Act” defines ByteDance, a China-based tech company, as a “foreign adversary.” The act aims […]
AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Gracell Biotechnologies Inc (NASDAQ: GRCL), further strengthening AstraZeneca’s cell therapy portfolio. The deal value is $2.00/share (equivalent to $10/ADS ADS of Gracell) plus a non-tradable contingent value right of $0.30/share (equivalent to $1.50/ADS of Gracell) in cash. The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies with GC012F, a […]
(Adds details in paragraphs 2-6) Dec 26 (Reuters) – AstraZeneca said on Tuesday it will buy China-based Gracell Biotechnologies for up to $1.2 billion as the British pharma company furthers its cell therapy ambitions. The cash deal aimed at bolstering AstraZeneca’s portfolio values U.S.-listed Gracell at $2 per ordinary share or $10 per ADS of […]